Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Cervical Cancer

  Free Subscription


1 Acta Obstet Gynecol Scand
1 AJR Am J Roentgenol
1 Am J Clin Pathol
1 Am J Nurs
1 Analyst
1 Biochem Biophys Res Commun
1 Biomed Res Int
1 BMB Rep
1 BMC Cancer
1 BMC Pregnancy Childbirth
1 Cancer Biother Radiopharm
1 Cancer Cell Int
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Manag Res
1 Cancer Sci
1 Cancers (Basel)
1 Clin Nucl Med
1 Curr Med Res Opin
1 Curr Pharm Des
1 Emerg Radiol
3 Enferm Clin
1 Eur Rev Med Pharmacol Sci
1 Front Genet
4 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
1 Int J Med Robot
1 Int J Med Sci
1 Int J Mol Med
1 Int J Oncol
1 J Biol Regul Homeost Agents
1 J Cancer
1 J Cancer Educ
1 J Cell Mol Med
2 J Cell Physiol
1 J Clin Lab Anal
1 J Gynecol Obstet Hum Reprod
1 J Minim Invasive Gynecol
1 J Paediatr Child Health
1 J Racial Ethn Health Disparities
1 Jpn J Radiol
1 Medicine (Baltimore)
1 Mol Genet Genomic Med
1 N Z Med J
1 Nature
2 Onco Targets Ther
1 Oncol Rep
1 Pathol Res Pract
1 Phys Med
1 Prev Med Rep
1 Public Health
1 Radiat Oncol
2 Radiother Oncol
1 Transgend Health
1 Virchows Arch

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Obstet Gynecol Scand

  1. RAFFONE A, Travaglino A, D'Antonio A, De Marco M, et al
    Immunohistochemistry for BAG3 in cervical precancerous lesions.
    Acta Obstet Gynecol Scand. 2020;99:295-296.

    AJR Am J Roentgenol

  2. CONSUL N, Menias CO, Lubner MG, Katabathina VS, et al
    A Review of Viral-Related Malignancies and the Associated Imaging Findings.
    AJR Am J Roentgenol. 2019 Oct 8:1-10. doi: 10.2214/AJR.19.21357.
    PubMed         Abstract available

    Am J Clin Pathol

  3. HAN M, Li J, Austin M, Varma KR, et al
    Human Papillomavirus (HPV) 16 and 18/45 Genotyping-Directed Follow-up of Women With Messenger RNA HPV-Positive, Cytology-Negative Cervical Screening Test Results.
    Am J Clin Pathol. 2020;153:243-250.
    PubMed         Abstract available

    Am J Nurs

    Any Number of HPV Vaccine Doses Reduces Risk of Cervical Cancer.
    Am J Nurs. 2020;120:71.


  5. MILETIC M, Askrabic S, Ruger J, Vasic B, et al
    Combined Raman and AFM detection of changes in HeLa cervical cancer cells induced by CeO2 nanoparticles - molecular and morphological perspectives.
    Analyst. 2020 Apr 23. doi: 10.1039/c9an02518.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  6. LEE HJ, Kim MJ, Kim YS, Choi MY, et al
    UHRF1 silences gelsolin to inhibit cell death in early stage cervical cancer.
    Biochem Biophys Res Commun. 2020 Apr 17. pii: S0006-291X(20)30689.
    PubMed         Abstract available

    Biomed Res Int

  7. ZHANG F, Yao M, Lin Z, Chen Y, et al
    The Effects of Preoperative Oral Carbohydrate on Frequency of T and NK Cells in Patients with Cervical Cancer Treated Using Neoadjuvant Chemotherapy and Surgery: A Prospective Cohort Study.
    Biomed Res Int. 2020;2020:2101480.
    PubMed         Abstract available


  8. SKORSTENGAARD M, Lynge E, Suhr J, Napolitano G, et al
    Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.
    BJOG. 2020;127:729-736.
    PubMed         Abstract available

    BMB Rep

  9. KIM DH, Lee HW, Park HW, Lee HW, et al
    Bee venom inhibits the proliferation and migration of cervical-cancer cells in an HPV E6/E7-dependent manner.
    BMB Rep. 2020 Apr 22. pii: 4939.
    PubMed         Abstract available

    BMC Cancer

  10. LI C, Li Y, Yan Z, Dai S, et al
    Polymorphisms in endoplasmic reticulum aminopeptidase genes are associated with cervical cancer risk in a Chinese Han population.
    BMC Cancer. 2020;20:341.
    PubMed         Abstract available

    BMC Pregnancy Childbirth

  11. SHINKAI S, Ishioka S, Mariya T, Fujibe Y, et al
    Pregnancies after vaginal radical trachelectomy (RT) in patients with early invasive uterine cervical cancer: results from a single institute.
    BMC Pregnancy Childbirth. 2020;20:248.
    PubMed         Abstract available

    Cancer Biother Radiopharm

  12. LUO H, Zhang J, He Z, Wu S, et al
    Long Noncoding RNA WT1-AS Inhibits the Progression of Cervical Cancer by Sponging miR-205.
    Cancer Biother Radiopharm. 2020 Apr 22. doi: 10.1089/cbr.2019.3279.
    PubMed         Abstract available

    Cancer Cell Int

  13. CAO Q, Wang N, Ren L, Tian J, et al
    miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway.
    Cancer Cell Int. 2020;20:117.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

  14. MALAGON T, Mayrand MH, Ogilvie G, Gotlieb WH, et al
    Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 24. pii: 1055-9965.EPI-20-0190.
    PubMed         Abstract available

    Cancer Manag Res

  15. TANG X, Liu S, Ding Y, Guo C, et al
    Serum Circular FoxO3a Serves as a Novel Prognostic Biomarker in Squamous Cervical Cancer.
    Cancer Manag Res. 2020;12:2531-2540.
    PubMed         Abstract available

  16. Long Noncoding RNA ZFPM2-AS1 Enhances the Malignancy of Cervical Cancer by Functioning as a Molecular Sponge of microRNA-511-3p and Consequently Increasing FGFR2 Expression [Retraction].
    Cancer Manag Res. 2020;12:2367.
    PubMed         Abstract available

    Cancer Sci

    Is the catch-up program of HPV vaccination for Japanese adult women effective or not?
    Cancer Sci. 2020;111:1435-1436.

    Cancers (Basel)

  18. WOOD J, Yasmin-Karim S, Mueller R, Viswanathan AN, et al
    Single Radiotherapy Fraction with Local Anti-CD40 Therapy Generates Effective Abscopal Responses in Mouse Models of Cervical Cancer.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

    Clin Nucl Med

  19. LEMAY J, Bouchard M, Rousseau E
    Radiation Recall Myositis Detected With 18F-FDG PET/CT After a Treatment of Cervical Cancer.
    Clin Nucl Med. 2020 Apr 21. doi: 10.1097/RLU.0000000000003024.
    PubMed         Abstract available

    Curr Med Res Opin

  20. SHAO C, He J, Stein K, Keefe S, et al
    Chemotherapy treatments, costs of care, and survival for elderly patients diagnosed with cervical cancer: an observational study.
    Curr Med Res Opin. 2020 Apr 21:1. doi: 10.1080/03007995.2020.1758928.
    PubMed         Abstract available

    Curr Pharm Des

  21. BALMAGAMBETOVA S, Tinelli A, Mynbaev OA, Koyshybaev A, et al
    Human Papillomavirus Selected Properties And Related Cervical Cancer Prevention Issues.
    Curr Pharm Des. 2020 Apr 21. pii: CPD-EPUB-105998.
    PubMed         Abstract available

    Emerg Radiol

  22. SIMSTEIN R, Merenich W, Graber J, Ferrell M, et al
    A case report of ovarian torsion following ovarian transposition for cervical cancer.
    Emerg Radiol. 2020 Apr 19. pii: 10.1007/s10140-020-01776.
    PubMed         Abstract available

    Enferm Clin

  23. HARTATI S, Winarti R
    Mother's knowledge level about cervical cancer in East Jakarta area.
    Enferm Clin. 2020;30 Suppl 3:108-112.
    PubMed         Abstract available

  24. DEVARA CAD, Haryani, Hapsari ED
    Validity and reliability of Cervical Cancer Awareness Measure (Cervical CAM) Indonesian version.
    Enferm Clin. 2020;30 Suppl 3:35-39.
    PubMed         Abstract available

  25. IMELDA F, Darti NA, Siregar FLS
    Effectiveness of physical exercise toward decreased fatigue in cervical cancer.
    Enferm Clin. 2020;30 Suppl 3:127-131.
    PubMed         Abstract available

    Eur Rev Med Pharmacol Sci

  26. WEI H, Qiu YQ, Zeng QS, Wang SF, et al
    LncRNA UCA1 regulates proliferation, migration and invasion of cervical cancer cells by targeting miR-145.
    Eur Rev Med Pharmacol Sci. 2020;24:3555-3564.
    PubMed         Abstract available

    Front Genet

  27. ZHU H, Zhu H, Tian M, Wang D, et al
    DNA Methylation and Hydroxymethylation in Cervical Cancer: Diagnosis, Prognosis and Treatment.
    Front Genet. 2020;11:347.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  28. BULE YP, Silva J, Carrilho C, Campos C, et al
    Human papillomavirus prevalence and distribution in self-collected samples from female university students in Maputo.
    Int J Gynaecol Obstet. 2020;149:237-246.
    PubMed         Abstract available

  29. KURIAKOSE S, Sabeena S, Binesh D, Abdulmajeed J, et al
    Diagnostic accuracy of self-collected vaginal samples for HPV DNA detection in women from South India.
    Int J Gynaecol Obstet. 2020 Feb 9. doi: 10.1002/ijgo.13116.
    PubMed         Abstract available

  30. NODJIKOUAMBAYE ZA, Adawaye C, Bouassa RM, Sadjoli D, et al
    A systematic review of self-sampling for HPV testing in Africa.
    Int J Gynaecol Obstet. 2020 Feb 9. doi: 10.1002/ijgo.13112.
    PubMed         Abstract available

  31. LARA-PENARANDA R, Rodriguez-Lopez PM, Plitt-Stevens J, Ortiz-Gonzalez A, et al
    Does the trend toward less deep excisions in LLETZ to minimize obstetric risk lead to less favorable oncological outcomes?
    Int J Gynaecol Obstet. 2019 Dec 8. doi: 10.1002/ijgo.13080.
    PubMed         Abstract available

    Int J Gynecol Cancer

  32. NUNES DE ARRUDA F, da Costa S, Bonadio R, Dornellas A, et al
    Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
    Int J Gynecol Cancer. 2020 Apr 21. pii: ijgc-2019-001134.
    PubMed         Abstract available

    Int J Med Robot

  33. PATEL H, Madhuri K, Rockell T, Montaser R, et al
    Robotic Radical Hysterectomy for Stage 1B1 Cervical Cancer: A Case Series of Survival Outcomes from a Leading UK Cancer Centre.
    Int J Med Robot. 2020 Apr 21:e2116. doi: 10.1002/rcs.2116.
    PubMed         Abstract available

    Int J Med Sci

  34. DAI S, Li C, Yan Z, Zhou Z, et al
    Association of Human Papillomavirus Type 16 Long Control Region Variations with Cervical Cancer in a Han Chinese Population.
    Int J Med Sci. 2020;17:931-938.
    PubMed         Abstract available

    Int J Mol Med

  35. SUN R, Guan H, Liu W, Liang J, et al
    Expression of BMP7 in cervical cancer and inhibition of epithelialmesenchymal transition by BMP7 knockdown in HeLa cells.
    Int J Mol Med. 2020 Feb 27. doi: 10.3892/ijmm.2020.4519.
    PubMed         Abstract available

    Int J Oncol

  36. LIAO S, Liang L, Yue C, He J, et al
    CD38 is involved in cell energy metabolism via activating the PI3K/AKT/mTOR signaling pathway in cervical cancer cells.
    Int J Oncol. 2020 Apr 8. doi: 10.3892/ijo.2020.5040.
    PubMed         Abstract available

    J Biol Regul Homeost Agents

  37. KAN XQ, Li YB, He B, Cheng S, et al
    MiR-1294 acts as a tumor inhibitor in cervical cancer by regulating FLOT1 expression.
    J Biol Regul Homeost Agents. 2020;34.
    PubMed         Abstract available

    J Cancer

  38. WANG Z, Wang T, Yang J, Wang W, et al
    Diagnostic Yield and Performance of a Large Population-Based Cervical Cancer Screening Program in High-Risk Rural China.
    J Cancer. 2020;11:4000-4006.
    PubMed         Abstract available

    J Cancer Educ

  39. LIEBERMANN E, Van Devanter N, Frias Guzman N, Hammer MJ, et al
    Dominican Provider Attitudes Towards HPV Testing for Cervical Cancer Screening and, Current Challenges to Cervical Cancer Prevention in the Dominican Republic: a Mixed Methods Study.
    J Cancer Educ. 2020 Apr 19. pii: 10.1007/s13187-020-01746.
    PubMed         Abstract available

    J Cell Mol Med

  40. GONG J, Fan H, Deng J, Zhang Q, et al
    LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74.
    J Cell Mol Med. 2020 Apr 21. doi: 10.1111/jcmm.15117.
    PubMed         Abstract available

    J Cell Physiol

  41. WEN D, Huang Z, Li Z, Tang X, et al
    LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA.
    J Cell Physiol. 2020 Apr 23. doi: 10.1002/jcp.29667.
    PubMed         Abstract available

  42. LIN CS, Lin CL, Ying TH, Chiou HL, et al
    beta-Mangostin inhibits the metastatic power of cervical cancer cells attributing to suppression of JNK2/AP-1/Snail cascade.
    J Cell Physiol. 2020 Apr 23. doi: 10.1002/jcp.29688.
    PubMed         Abstract available

    J Clin Lab Anal

  43. HE J, Lv X, Zeng Z
    A potential disease monitoring and prognostic biomarker in cervical cancer patients: The clinical application of circular RNA_0018289.
    J Clin Lab Anal. 2020 Apr 22:e23340. doi: 10.1002/jcla.23340.
    PubMed         Abstract available

    J Gynecol Obstet Hum Reprod

  44. KNIGHT S, Mancini J, Touboul C, Bolze PA, et al
    J Gynecol Obstet Hum Reprod. 2020 Apr 21:101774.
    PubMed         Abstract available

    J Minim Invasive Gynecol

  45. CASARIN J, Bogani G, Papadia A, Ditto A, et al
    Preoperative conization and risk of recurrence in patients undergoing laparoscopic radical hysterectomy for early-stage cervical cancer. A multicenter study.
    J Minim Invasive Gynecol. 2020 Apr 19. pii: S1553-4650(20)30190.
    PubMed         Abstract available

    J Paediatr Child Health

  46. Human papillomavirus vaccine to prevent cervical cancer globally.
    J Paediatr Child Health. 2020;56:657.

    J Racial Ethn Health Disparities

  47. GHOSH S, Mallya SD, Shetty RS, Pattanshetty SM, et al
    Knowledge, Attitude and Practices Towards Cervical Cancer and its Screening Among Women from Tribal Population: a Community-Based Study from Southern India.
    J Racial Ethn Health Disparities. 2020 Apr 24. pii: 10.1007/s40615-020-00760.
    PubMed         Abstract available

    Jpn J Radiol

  48. IWAI Y, Nemoto MW, Horikoshi T, Kanazawa A, et al
    Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the
    Jpn J Radiol. 2020 Apr 24. pii: 10.1007/s11604-020-00980.
    PubMed         Abstract available

    Medicine (Baltimore)

  49. ZENG J, Qu P, Hu Y, Sun P, et al
    Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Medicine (Baltimore). 2020;99:e19714.
    PubMed         Abstract available

    Mol Genet Genomic Med

  50. GAO Z, Xiong Z, Sun Y, Wu J, et al
    CASC15 polymorphisms are correlated with cervical cancer susceptibility in Chinese women.
    Mol Genet Genomic Med. 2020 Apr 23:e1246. doi: 10.1002/mgg3.1246.
    PubMed         Abstract available

    N Z Med J

  51. INNES CR, Williman JA, Simcock BJ, Hider P, et al
    Impact of human papillomavirus vaccination on rates of abnormal cervical cytology and histology in young New Zealand women.
    N Z Med J. 2020;133:72-84.
    PubMed         Abstract available


    A global drive to eliminate cervical cancer.
    Nature. 2020;580:S2-S4.

    Onco Targets Ther

  53. TIAN J, Kong E, Wang X, Xie Z, et al
    RSF-1 siRNA Enhances Tumor Radiosensitivity in Cervical Cancer via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis.
    Onco Targets Ther. 2020;13:3061-3071.
    PubMed         Abstract available

  54. GU X, Dong M, Liu Z, Yang J, et al
    MiR-499a-5p Inhibits Proliferation, Invasion, Migration, and Epithelial-Mesenchymal Transition, and Enhances Radiosensitivity of Cervical Cancer Cells via Targeting eIF4E.
    Onco Targets Ther. 2020;13:2913-2924.
    PubMed         Abstract available

    Oncol Rep

  55. CHEN X, Liu W, Guo X, Huang S, et al
    Ropivacaine inhibits cervical cancer cell growth via suppression of the miR96/MEG2/pSTAT3 axis.
    Oncol Rep. 2020 Feb 26. doi: 10.3892/or.2020.7521.
    PubMed         Abstract available

    Pathol Res Pract

  56. YUAN Y, Shi X, Li B, Peng M, et al
    Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
    Pathol Res Pract. 2020 Apr 8:152952. doi: 10.1016/j.prp.2020.152952.
    PubMed         Abstract available

    Phys Med

  57. SUKHIKH ES, Sukhikh LG, Lushnikova PA, Tatarchenko MA, et al
    Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer.
    Phys Med. 2020;73:83-88.
    PubMed         Abstract available

    Prev Med Rep

  58. MOUCHERAUD C, Kawale P, Kafwafwa S, Bastani R, et al
    "It is big because it's ruining the lives of many people in Malawi": Women's attitudes and beliefs about cervical cancer.
    Prev Med Rep. 2020;18:101093.
    PubMed         Abstract available

    Public Health

  59. AVNI-SINGER LR, Yakely A, Sheth SS, Shapiro ED, et al
    Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis.
    Public Health. 2020;178:137-150.
    PubMed         Abstract available

    Radiat Oncol

  60. PARK SH, Hahm MH, Bae BK, Chong GO, et al
    Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
    Radiat Oncol. 2020;15:86.
    PubMed         Abstract available

    Radiother Oncol

  61. REIJTENBAGH DMW, Godart J, Mens JM, Heijkoop ST, et al
    Patient-reported acute GI symptoms in locally advanced cervical cancer patients correlate with rectal dose.
    Radiother Oncol. 2020;148:38-43.
    PubMed         Abstract available

  62. LI Z, Tamari K, Seo Y, Minami K, et al
    Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening.
    Radiother Oncol. 2020;148:21-29.
    PubMed         Abstract available

    Transgend Health

  63. GOLDSTEIN Z, Martinson T, Ramachandran S, Lindner R, et al
    Improved Rates of Cervical Cancer Screening Among Transmasculine Patients Through Self-Collected Swabs for High-Risk Human Papillomavirus DNA Testing.
    Transgend Health. 2020;5:10-17.
    PubMed         Abstract available

    Virchows Arch

  64. ASAKA S, Nakajima T, Kugo K, Kashiwagi R, et al
    Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Mullerian-type.
    Virchows Arch. 2020;476:499-510.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.